Patterns of Ambulatory Medical Care Utilization and Rheumatologist Consultation Predating the Diagnosis of Systemic Lupus Erythematosus: A National Population-Based Study

Abstract

ObjectiveTo investigate the records of ambulatory medical care from patients predating the diagnosis of systemic lupus erythematosus (SLE) using nationwide, population-based claims data.MethodsThe frequencies and costs of ambulatory medical care utilization in 337 newly-diagnosed SLE cases between 2004 and 2010, identified from Taiwan's National Health Insurance Research Database, were compared with 1,348 controls who were frequency matched for sex, age, and the catastrophic illness certificate application year of the cases.ResultsPatients with SLE had a median frequency of ambulatory medical care utilization compared with controls one year prior to the index date (22 vs. 2, P<0.001). The differences were significant throughout all eight annual periods. Similarly, the inflation-adjusted costs of ambulatory medical care utilization in patients with SLE increased annually over the study period, from a median of US$18 eight years prior to the index date to US$680 one year prior to the index date. Diseases of the respiratory system (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 460–519), digestive system (ICD-9-CM codes 520–579), musculoskeletal system and connective tissue (ICD-9-CM codes 710–739, excluding 710.0), and skin and subcutaneous tissue (ICD-9-CM codes 680–709) were the top four common causes of visits in the 0.5 to 2 year period preceding the index date and percentages of SLE patients suffered from these disorders increased progressively over the study period. Only 56.4% of the patients with SLE had consulted a rheumatologist and most of the serology tests were done within one year predating the index date.ConclusionsIncreased frequencies and costs of ambulatory care utilization among Taiwanese patients with SLE occurred several years predating their definitive SLE diagnosis. When multisystemic disorders are presented in young female patients, the possibility of SLE should be considered and screened with tools such as the antinuclear antibody test.

Obstructive sleep apnea and risk of Parkinson's disease: a population‐based cohort study

“…First, the diagnoses of OSA, PD and other comorbidities based on ICD-9-CM might lead to potential misclassification bias. However, the use of ICD-9-CM for patients with chronic diseases has been validated in previous national cohort studies (Chen et al, 2011;Lai et al, 2014;Tsai et al, 2013), and misclassification (if any) was likely to be random and thereby tended to underestimate rather than overestimate the relative risk. Furthermore, the Taiwan NHI samples claims randomly from hospitals, interviews patients and reviews medical charts to verify the accuracy of medical records (National Health Institute, 2011).…”

Risk of epilepsy in patients with systemic lupus erythematosus &ndash; a retrospective cohort study

“…However, certain limitations are still present in this study. Although SLE is considered to be a severe catastrophic illness in Taiwan, and although patients are registered with the physician’s approval and evaluation by the National Bureau of Insurance, some patients are reluctant to apply for catastrophic care, and these patients may thus be included in the non-SLE cohort 39. However, the size of this population is likely to be insignificant.…”

Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model

“…In comparison, our study was larger, from a more diverse population and included a control group. A Taiwanese insurance claims study (17) found increased use of medical care in the eight years preceding SLE diagnosis. A shorter time period was used for our study to increase the number of participants with complete data and increase the chance that clinical features were attributable to SLE.…”